Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major Depression
Primary Purpose
Major Depression
Status
Unknown status
Phase
Phase 4
Locations
Germany
Study Type
Interventional
Intervention
partial sleep deprivation
Sponsored by
About this trial
This is an interventional treatment trial for Major Depression
Eligibility Criteria
Inclusion Criteria: Major depression Informed consent Exclusion Criteria: Known epilepsy or previous unexplained loss of consciousness after sleep deprivation Bipolar disorder Acute or chronic inflammatory diseases Psychosis Suicidal tendency Pregnancy or nursing
Sites / Locations
- Zentrum für Integrative Psychiatrie
Outcomes
Primary Outcome Measures
cognition
cytokine concentration
Secondary Outcome Measures
clinical improvement
Full Information
NCT ID
NCT00291239
First Posted
February 9, 2006
Last Updated
April 2, 2009
Sponsor
Zentrum für Integrative Psychiatrie
Collaborators
German Research Foundation
1. Study Identification
Unique Protocol Identification Number
NCT00291239
Brief Title
Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major Depression
Official Title
Phase 4 Study on the Effect of Partial Sleep Deprivation on Cognition and the IL-6-gp130-System in Individuals With Major Depression
Study Type
Interventional
2. Study Status
Record Verification Date
April 2009
Overall Recruitment Status
Unknown status
Study Start Date
February 2006 (undefined)
Primary Completion Date
December 2008 (Actual)
Study Completion Date
July 2009 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Zentrum für Integrative Psychiatrie
Collaborators
German Research Foundation
4. Oversight
5. Study Description
Brief Summary
40 patients with the diagnosis of major depression are included. There are two interventions: partial sleep deprivation (PSD) and normal night sleep (CTRL). Patients are randomly assigned to PSD-(2 undisturbed nights)-CTRL or CTRL-(2 undisturbed nights)-PSD. Cytokine-status, neuropsychological and psychopathometric status are assessed pre and post each interventional and control condition.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Major Depression
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
partial sleep deprivation
Primary Outcome Measure Information:
Title
cognition
Title
cytokine concentration
Secondary Outcome Measure Information:
Title
clinical improvement
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Major depression
Informed consent
Exclusion Criteria:
Known epilepsy or previous unexplained loss of consciousness after sleep deprivation
Bipolar disorder
Acute or chronic inflammatory diseases
Psychosis
Suicidal tendency
Pregnancy or nursing
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dunja Hinze-Selch, MD
Organizational Affiliation
Zentrum für Integrative Psychiatrie
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zentrum für Integrative Psychiatrie
City
Kiel
ZIP/Postal Code
24105
Country
Germany
12. IPD Sharing Statement
Learn more about this trial
Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major Depression
We'll reach out to this number within 24 hrs